Lepu Scientech Medical Technology (Shanghai) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
310.00
191.00
-17.00
79.00
86.00
68.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
-55.00
16.00
-3.00
-2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
250.00
193.00
77.00
126.00
66.00
61.00
Cash Flow from Investing Activities
-136.00
111.00
-472.00
-102.00
-9.00
-14.00
Cash Flow from Financing Activities
-213.00
-2.00
671.00
810.00
-53.00
-47.00
Net Cash Inflow / Outflow
-98.00
295.00
269.00
837.00
3.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
-6.00
-7.00
2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lepu Scientech Medical Technology (Shanghai) Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
310.187087828155
284.108931466008
26.00
9.18%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0
-178.308200466745
178.00
100.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
250.83971180645
309.320388475762
-59.00
-18.91%
Cash Flow from Investing Activities
-136.702238949129
508.984545968316
-644.00
-126.86%
Cash Flow from Financing Activities
-213.491775345869
-540.659061303239
327.00
60.51%
Net Cash Inflow / Outflow
-98.3340362298726
291.392747239952
-389.00
-133.75%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.02026625867622
13.7468740991132
-12.00
-92.58%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 29.70% vs 150.76% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
250.84
193.40
29.70%






